A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care.
Diabetes Metab Syndr
; 16(12): 102658, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36371968
ABSTRACT
BACKGROUND AND AIMS:
Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) are associated with diabetic ketoacidosis (DKA), however limited case series are published.METHODS:
We evaluated the characteristics of patients admitted with SGLT-2i associated DKA.RESULTS:
Over 4 months, 22 patients were identified; 45.5% of DKA was not associated with concurrent illness.CONCLUSION:
DKA is not uncommonly associated with SGLT2i with no clear patient factors associated with severity.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Cetoacidosis Diabética
/
Diabetes Mellitus Tipo 2
/
Inhibidores del Cotransportador de Sodio-Glucosa 2
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Diabetes Metab Syndr
Año:
2022
Tipo del documento:
Article